Desperate Housewives Actress Marcia Cross Says She Feels “Liberated” After Sharing Her Battle with Anal Cancer

Actress Marcia Cross, best known for her role as Bree Van de Kamp on Desperate Housewives, has shared that she is now healthy after battling anal cancer in a series…

Continue Reading Desperate Housewives Actress Marcia Cross Says She Feels “Liberated” After Sharing Her Battle with Anal Cancer

A Marketing Application for the Gene Therapy LentiGlobin as a Treatment for Beta-Thalassemia is Being Reviewed in Europe

According to a recent press release from Bluebird Bio, the European Medicines Agency has accepted and will review their marketing authorization application (MAA) for the investigational gene therapy LentiGlobin™ as…

Continue Reading A Marketing Application for the Gene Therapy LentiGlobin as a Treatment for Beta-Thalassemia is Being Reviewed in Europe
Plans for a Clinical Trial of Coversin in Patients With Thrombotic Microangiopathies Have Been Announced
mohamed_hassan / Pixabay

Plans for a Clinical Trial of Coversin in Patients With Thrombotic Microangiopathies Have Been Announced

A drug called Coversin is being investigated as a potential treatment for four orphan diseases: bullous pemphigoid (BP), atypical keratoconjunctivitis (AKC), thrombotic microangiopathies, and paroxysmal nocturnal hemoglobinuria (PNH). Recently, new…

Continue Reading Plans for a Clinical Trial of Coversin in Patients With Thrombotic Microangiopathies Have Been Announced
She was Diagnosed with Ovarian Cancer at Age Five– Now She’s Advocating for More Research
FotoshopTofs / Pixabay

She was Diagnosed with Ovarian Cancer at Age Five– Now She’s Advocating for More Research

According to a story from 9news.com.au, the first sign that Jemima Leydon had ovarian cancer was a stomachache. Her mother Megan assumed that it was just a stomach bug that…

Continue Reading She was Diagnosed with Ovarian Cancer at Age Five– Now She’s Advocating for More Research
Arikayce® Granted Accelerated Approval by the FDA for the Treatment of MAC Lung Disease
jniittymaa0 / Pixabay

Arikayce® Granted Accelerated Approval by the FDA for the Treatment of MAC Lung Disease

A new drug designed to treat MAC lung disease as part of a combination antibacterial drug regimen in adults with limited treatment options has been granted Accelerated Approval by the…

Continue Reading Arikayce® Granted Accelerated Approval by the FDA for the Treatment of MAC Lung Disease
After Reviewing Publications About MPS III, Researchers Say More Studies Need to be Carried Out
jarmoluk / Pixabay

After Reviewing Publications About MPS III, Researchers Say More Studies Need to be Carried Out

Researchers have carried out a literature review to investigate MPS III. After reviewing forty-six papers, they concluded that more research needs to be carried out. You can find the original study…

Continue Reading After Reviewing Publications About MPS III, Researchers Say More Studies Need to be Carried Out
The FDA has Approved a New Cancer Drug Called Copiktra™ (duvelisib)
qimono / Pixabay

The FDA has Approved a New Cancer Drug Called Copiktra™ (duvelisib)

The United States Food and Drug Administration has approved Copiktra™ (duvelisib). The drug is now approved as a treatment for adult patients diagnosed with refractory or relapsed chronic lymphocytic leukaemia…

Continue Reading The FDA has Approved a New Cancer Drug Called Copiktra™ (duvelisib)

A Study of a Potential Drug for Primary Biliary Cholangitis has Exceeded its Patient Enrolment Target

The company Genkyotex has announced that they have finished enrolling participants for a Phase 2 clinical trial of the investigational drug GKT831 in patients who have primary biliary cholangitis. The…

Continue Reading A Study of a Potential Drug for Primary Biliary Cholangitis has Exceeded its Patient Enrolment Target
Data from Studies of a Potential Drug for Spinal Muscular Atrophy Show Very Encouraging Results
rawpixel / Pixabay

Data from Studies of a Potential Drug for Spinal Muscular Atrophy Show Very Encouraging Results

Encouraging interim data has been shared from two studies of risdiplam (RG7916), a drug being researched as a potential treatment for spinal muscular atrophy types 1, 2, and 3. For…

Continue Reading Data from Studies of a Potential Drug for Spinal Muscular Atrophy Show Very Encouraging Results
Study Highlights The Need For Precision in CAR-T Cell Therapies
allinonemovie / Pixabay

Study Highlights The Need For Precision in CAR-T Cell Therapies

According to a story from MedCity News, a recent study revealed a potential weakness of CAR-T cell immunotherapies that reveals the need for precision and caution in the extraction process.…

Continue Reading Study Highlights The Need For Precision in CAR-T Cell Therapies
Despite Effectiveness, Accelerated Approval For Acute Hepatic Porphyria Drug in Doubt
Arcaion / Pixabay

Despite Effectiveness, Accelerated Approval For Acute Hepatic Porphyria Drug in Doubt

According to a story from wtvbam.com, the drug development company Alnylam Pharmaceuticals has recently stated that it is looking less likely that its gene silencing therapy givosiran will be getting…

Continue Reading Despite Effectiveness, Accelerated Approval For Acute Hepatic Porphyria Drug in Doubt